Diagnostic value of tests for Taxoplasma gondii-specific antibodies in patients undergoing bone marrow transplantation

Clinical Laboratory

Volumn 49, Issue 5-6, 2003, Pages 239-242

  Janitschke, Klaus ^a   Held, Thomas ^b   Krüger, Dominique ^a   Schwedtfeger, Rainer ^c   Schlier, Gabriele ^a   Liesenfeld, Oliver ^d  

^a ROBERT KOCH INSTITUTE   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bone marrow transplantation; PCR; Serology; Toxoplasma gondii

Indexed keywords

ANTIPARASITIC AGENT; AXSYM-TOXO-IGG; AXSYM-TOXO-IGM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARASITE ANTIBODY; PLATELIA-TOXO-IGA; PYRIMETHAMINE; SULFADIAZINE; VIDAS-TOXO-IGG-AVIDITY; VIDAS-TOXO-IGM;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DONOR; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; PARASITEMIA; PATIENT MONITORING; POLYMERASE CHAIN REACTION; RECIPIENT; SCREENING TEST; SEROLOGY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; BONE MARROW TRANSPLANTATION; DNA, PROTOZOAN; HUMANS; IMMUNOCOMPROMISED HOST; POLYMERASE CHAIN REACTION; TOXOPLASMA; TOXOPLASMOSIS;

PROTOZOA; TOXOPLASMA GONDII;

EID: 0038411418     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Derouin F, Gluckman E, Beauvis B et al. Toxoplasma infection after human allogeneic bone marrow transplantation: Clinical and serological study of 80 patients. Bone Marrow Transplant 1986; 1: 67-73
2. Chandrasekar PH, Momin, F, Disseminated toxoplamosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant 1997; 19: 685-9
3. Sing A, Leitritz L, Rogenkamp A et al. Pulmonary toxoplasmosis in bone marrow transplant recipients: report of two cases and review. Clin Inf Dis 1999; 29: 429-33
4. Martino R, Maertens J, Bretagne S et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infec Dis 2000; 31: 1188-94
5. Mechain B, Garin YJ, Robert-Gangneux F, et al. Lack of utility of specific immunoglobulin G antibody avidity for serodiagnosis of reactivated toxoplasmosis in immunocompromised patients. Clin Diag Lab Imm 2000; 7: 703-5
6. Roemer E, Blau IW, Basara N et al. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience. Clin Infec Dis 2001; 32: 1-8
7. Held TK, Krüger D, Switala AR et al. Diagnosis of toxoplasmosis in bone marrow transplant recipients: comparison of PCR-based results and immunohistochemistry. Bone Marrow Transplant 2000; 25: 1257-62
8. Derouin F, Devergie A, Auber P et al. Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review. Clin Infec Dis 1992; 15: 267-70
9. Kupferschmidt O, Krüger D, Held TK, et al. Quantitative detection of Toxoplasma gondii DNA in human body fluids by TaqMan polymerase chain reaction. Clin Microbiol Infect 2001; 7: 120-4
10. Costa JM, Munoz C, Krüger D et al. Quality control for the diagnosis of Toxoplasma gondii reactivation in SCT patients using PCR assays. Bone Marrow Transplant 2001; 28: 527-28
11. Foot ABM, Garin YJF, Ribaud P et al. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansi-dar) in bone marrow transplant recipients. Bone Marrow Transplant 1994; 14: 241-45
12. Heurkens AHM, Koelma IA, de Planque MM et al. Failure to diagnose fatal disseminated toxoplasmosis in a bone marrow transplant recipient: the possible significance of declining antibody titres. J Infect 1989; 18: 283-88
13. Reiter-Owona I, Petersen E, Joynson D et al. The past and the present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis. Bull World Hlth Org 1999; 77: 929-35
14. Khoury H, Adkins D, Brown R et al. Successful treatment of cerebral toxoplasmosis in a marrow transplant recipient: contribution of a PCR test in diagnosis and early detection. Bone Marrow Transplant 1999; 23: 409-411